Cancel
Known information
- Received his PhD from UNC Chapel Hill where he studied molecular dynamics of diseased proteins
- Completed his postdoctoral fellowship at AstraZeneca
- Worked as an investigator at Novartis
- Leads the computational chemistry efforts, bridging the gap between AI, biology, and medicinal chemistry
About Arpeggio Bio
Arpeggio Bio, based in Boulder, CO, specializes in drug discovery targeting transcription factors with AI and RNA-sequencing technologies. The company, with a team of 20, collaborates with industry giants like J&J and FORMA, focusing on diseases such as IO-resistant melanoma and rare genetic disorders.
Report inaccurate information
